TG Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	454.07	329	233.66	2.79	6.69	0.15	Upgrade
Revenue Growth (YoY)	30.96%	40.80%	8290.02%	-58.36%	4300.66%	-	Upgrade
Cost of Revenue	59.22	38.49	14.13	0.27	0.79	-	Upgrade
Gross Profit	394.85	290.52	219.53	2.52	5.9	0.15	Upgrade
Selling, General & Admin	186.84	154.3	122.71	95.48	128.09	107.85	Upgrade
Research & Development	122.16	94.29	76.19	125.35	222.58	165.9	Upgrade
Operating Expenses	309	248.59	198.9	220.84	350.67	273.75	Upgrade
Operating Income	85.85	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
Interest Expense	-31.24	-24.03	-12.62	-10.19	-5.64	-6.33	Upgrade
Other Non Operating Income (Expenses)	11.5	7.69	5.04	4.7	2.31	0.54	Upgrade
Pretax Income	66.11	25.59	13.06	-223.81	-348.1	-279.38	Upgrade
Income Tax Expense	5.65	2.21	0.39	-	-	-	Upgrade
Net Income	60.46	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income to Common	60.46	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income Growth	-36.82%	84.52%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	146	145	142	135	132	115	Upgrade
Shares Outstanding (Diluted)	169	160	149	135	132	115	Upgrade
Shares Change (YoY)	11.99%	7.96%	9.67%	2.41%	14.64%	30.51%	Upgrade
EPS (Basic)	0.41	0.16	0.09	-1.65	-2.63	-2.42	Upgrade
EPS (Diluted)	0.36	0.15	0.09	-1.65	-2.63	-2.42	Upgrade
EPS Growth	-43.55%	68.03%	-	-	-	-	Upgrade
Free Cash Flow	-59.24	-40.56	-31.41	-176.18	-296.04	-214.86	Upgrade
Free Cash Flow Per Share	-0.35	-0.25	-0.21	-1.30	-2.24	-1.86	Upgrade
Gross Margin	86.96%	88.30%	93.95%	90.48%	88.19%	100.00%	Upgrade
Operating Margin	18.91%	12.74%	8.83%	-7838.99%	-5154.28%	-179996.05%	Upgrade
Profit Margin	13.31%	7.11%	5.42%	-8036.34%	-5204.08%	-183803.29%	Upgrade
Free Cash Flow Margin	-13.05%	-12.33%	-13.44%	-6326.18%	-4425.70%	-141357.90%	Upgrade
EBITDA	85.89	42	20.84	-218.01	-344.49	-273.44	Upgrade
EBITDA Margin	18.92%	12.77%	8.92%	-	-	-	Upgrade
D&A For EBITDA	0.04	0.07	0.21	0.3	0.28	0.16	Upgrade
EBIT	85.85	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
EBIT Margin	18.91%	12.74%	8.83%	-	-	-	Upgrade
Effective Tax Rate	8.55%	8.64%	2.99%	-	-	-	Upgrade
Revenue as Reported	454.07	329	233.66	2.79	6.69	0.15	Upgrade

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q